Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blenrep
Pharma
GSK readopts £3B peak sales estimate for myeloma ADC Blenrep
Two pivotal trial wins have rekindled hopes at GSK that once-failed multiple myeloma drug Blenrep could exceed 3 billion pounds in peak sales.
Angus Liu
Jun 17, 2024 3:22pm
GSK axes Blenrep combo studies with SpringWorks' Ogsiveo
Jun 10, 2024 10:20am
Sponsored
GSK's ADC Blenrep delivers survival win against J&J's Darzalex
Nov 14, 2024 9:24am
ASCO: GSK builds case for Blenrep's return in multiple myeloma
Jun 2, 2024 8:00am
With GSK's 2nd Blenrep win, analysts see blockbuster comeback
Mar 7, 2024 10:14am
GSK details combo data that could bring Blenrep back to life
Feb 5, 2024 5:00pm
